Immediate and Delayed Implant Placement Using Socket Shield Technique and Autogenous Dentin Graft

August 20, 2024 updated by: Hams Hamed Abdelrahman

Immediate And Delayed Implant Placement Using Socket Shield Technique And Autogenous Dentin Graft (A Randomized Clinical Trial)

One of the techniques that have been proposed to reduce the amount of bone resorption in anterior maxilla is the "socket shield (SS) ". This technique includes preservation of the facial segment of a root to be extracted and immediate implant placement. A technique of socket shield with delayed implantation using autogenous dentin graft for socket preservation, as an alternative to autogenous bone grafts, has shown predictable clinical and histological outcomes.

Study Overview

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt
        • Alexandria Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with badly destructed or non-restorable maxillary anterior teeth when the Labial cortical plate is still intact, and the thickness was found to be <2mm in CBCT.
  • Patients with health status according to American Society of Anesthesiology (ASA) I and II.
  • Patients who agree to participate in the study.

Exclusion Criteria:

  • Patients presenting with any systemic pathology or health condition that would inhibit the osseointegration process of the implants.
  • Perforated labial cortical plate seen in CBCT.
  • Patients undergoing radiation therapy or history of radiation within the last two years.
  • Drug or alcohol abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Immediate Implant with Socket Shield Group
Active Comparator: Group B
Delayed Implant with Socket preserved with socket Shield and dentin graft Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in implant stability
Time Frame: Baseline and 3 months
The stability of each implant will be measured using the Osstell device. The ISQ value will be measured immediately at the time of surgery and after three months
Baseline and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in thickness of the facial cortical plate
Time Frame: Baseline and 3 months
patients will be subjected to CBCT scans
Baseline and 3 months
Change in bone density
Time Frame: Baseline and 3 months
patients will be subjected to CBCT scans
Baseline and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2023

Primary Completion (Actual)

December 19, 2023

Study Completion (Actual)

December 19, 2023

Study Registration Dates

First Submitted

August 20, 2024

First Submitted That Met QC Criteria

August 20, 2024

First Posted (Actual)

August 22, 2024

Study Record Updates

Last Update Posted (Actual)

August 22, 2024

Last Update Submitted That Met QC Criteria

August 20, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 0629-2/2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Loss

Clinical Trials on Immediate implant

Subscribe